Patent · US Active

Xenograft soft tissue implants and methods of making

US11883437B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

Tutogen Medical GmbH · DE

Inventors

Arnd Wilhelmi · Forchheim, DE
Silke Schreiner · Erlangen, DE
Jake Michaelson · Gainesville, US
Steven Moore · Holly Springs, US
Jennifer Faleris · Alachua, US
Anne Reinlein · Bamberg, DE

Key dates

Filing date	Jun 10, 2022
Grant date	Jan 30, 2024
Priority date	—
Expiry date	Jul 29, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L27/3687
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.